Secondary outcomes
SECONDARY
PrEP acceptance, initiation, adherence, and duration, and partner HIV status (at 9 months postpartum) were secondary outcomes. PrEP acceptance was defined as participants who accepted PrEP at any visit. PrEP confirmation visit was defined as participant‐report of swallowing PrEP pills at visits after PrEP acceptance, with the PrEP initiation date defined as the median date between the PrEP acceptance and PrEP confirmation visits. At the PrEP confirmation visit, self‐reported PrEP adherence was dichotomized as no missed doses versus any missed doses in the past 30 days. The PrEP duration was defined as the time between the PrEP initiation date and discontinuation or study end [The proportion of women who accepted and used PrEP and self‐reported adherence was compared between arms using GEE with a Poisson link. Proportions of partner HIV status unknown and change in partner HIV status knowledge by the study end were compared between arms using GEE with a Poisson link. Mean PrEP duration was compared between arms using GEE with a Gaussian link.All analyses were conducted using Stata SE 17.0 (StataCorp, College Station, TX).